Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Method and system for determining an optimal missile intercept approach direction for correct remote sensor-to-seeker handover
Imaging lens having five lens elements, and electronic apparatus having the same
Pluggable power cell for an inverter
Formation of a masking layer on a dielectric region to facilitate formation of a capping layer on electrically conductive regions separated by the dielectric region
System and method for distributed security
Adding co-users to user definable co-user lists
  Randomly Featured Patents
Inductive sensor arrangement and measuring arrangement for use thereof
Antibodies with immune effector activity and that internalize in endosialin-positive cells
Metal-film laminate
Wireless network apparatus and method for lock indication
Paper hole detecting apparatus with slidable reflector
Self-cleaning filter apparatus
Pesticidal compositions
Portable, potable water recovery and dispensing apparatus
Lightning warning system
Blends of amorphous and semicrystalline polymers having shape memory properties